Microbot Medical (MBOT) EBIT Margin (2010 - 2026)

Microbot Medical (MBOT) posted EBIT Margin of 4114.29% for Q1 2026, down 2903.13% on a QoQ basis from 137.0% in Q1 2017.

Microbot Medical (MBOT) EBIT Margin (2010 - 2026) Analysis & Trends

Microbot Medical's EBIT Margin history runs 9 years deep, the most recent figure standing at 4114.29% for Q1 2026.

Quarterly EBIT Margin changed N/A year-over-year to 4114.29% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1376.38% (changed N/A YoY) and the FY2017 annual result came in at 2942.46%, up 746593.0% from the prior year.
EBIT Margin was 4114.29% for Q1 2026 at Microbot Medical, down from 137.0% in the prior quarter.
Across five years, EBIT Margin topped out at 4114.29% in Q1 2026 and bottomed at 4114.29% in Q1 2026.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBIT Margin (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	98.77%
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	33.60%
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	1.97%
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	5.74%
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	34.92%
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	20.53%
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	-2.87%
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	4.04%
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	13.65%
10	Microbot Medical	27.53 Mn	27.53 Mn	2,000.00	-4,114.29%

Historic Data

Download Data

Date	Value
Mar 31, 2026	-4,114.29%
Mar 31, 2017	-137.00%
Dec 31, 2016	-6,192.72%
Sep 30, 2016	-1,968.74%
Jun 30, 2016	402.58%
Mar 31, 2016	1,230.36%
Dec 31, 2015	100,468.63%
Sep 30, 2015	-26,972.54%
Jun 30, 2015	-30,774.23%
Mar 31, 2015	-42,674.62%
Dec 31, 2014	-1,101.83%
Sep 30, 2014	-7,779.98%
Jun 30, 2014	-34,606.54%
Mar 31, 2014	-28,508.76%
Dec 31, 2013	-19,907.16%
Sep 30, 2013	-17,515.96%
Jun 30, 2013	-18,852.32%
Mar 31, 2013	-11,173.48%
Dec 31, 2012	-2,917.39%
Sep 30, 2012	-1,923.19%